Bio-Techne to Present at the BofA Securities 2025 Health Care Conference
Bio-Techne Corporation (NASDAQ: TECH) has announced that its President and CEO, Kim Kelderman, will present at the BofA Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 10:40 a.m. PDT. Investors and interested parties can access a live webcast of the presentation through Bio-Techne's Investor Relations website, specifically on the IR Calendar page.
Bio-Techne Corporation (NASDAQ: TECH) ha annunciato che il suo Presidente e CEO, Kim Kelderman, terrà una presentazione al BofA Securities 2025 Health Care Conference martedì 13 maggio 2025 alle 10:40 PDT. Investitori e interessati potranno seguire la diretta streaming della presentazione sul sito web delle Relazioni con gli Investitori di Bio-Techne, nella pagina del Calendario IR.
Bio-Techne Corporation (NASDAQ: TECH) ha anunciado que su Presidente y CEO, Kim Kelderman, presentará en la BofA Securities 2025 Health Care Conference el martes 13 de mayo de 2025 a las 10:40 a.m. PDT. Los inversionistas y partes interesadas podrán acceder a la transmisión en vivo de la presentación a través del sitio web de Relaciones con Inversionistas de Bio-Techne, específicamente en la página del Calendario IR.
Bio-Techne Corporation (NASDAQ: TECH)는 사장 겸 CEO인 Kim Kelderman이 2025년 5월 13일 화요일 오전 10시 40분(PDT)에 개최되는 BofA Securities 2025 Health Care Conference에서 발표할 예정임을 발표했습니다. 투자자와 관심 있는 분들은 Bio-Techne 투자자 관계 웹사이트의 IR 일정 페이지를 통해 발표 실시간 웹캐스트를 시청할 수 있습니다.
Bio-Techne Corporation (NASDAQ: TECH) a annoncé que son président et CEO, Kim Kelderman, présentera lors de la BofA Securities 2025 Health Care Conference le mardi 13 mai 2025 à 10h40 PDT. Les investisseurs et parties intéressées pourront accéder à la diffusion en direct de la présentation via le site web des Relations Investisseurs de Bio-Techne, notamment sur la page du calendrier IR.
Bio-Techne Corporation (NASDAQ: TECH) hat bekannt gegeben, dass sein Präsident und CEO, Kim Kelderman, am Dienstag, den 13. Mai 2025 um 10:40 Uhr PDT auf der BofA Securities 2025 Health Care Conference präsentieren wird. Investoren und Interessierte können die Live-Webcast-Präsentation über die Investor-Relations-Website von Bio-Techne, speziell auf der IR-Kalenderseite, verfolgen.
- None.
- None.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated approximately
Contact: | David Clair, Vice President, Investor Relations & Corporate Development |
612-656-4416 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-the-bofa-securities-2025-health-care-conference-302448431.html
SOURCE Bio-Techne Corporation